EWA
GILD icon

Exencial Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Exencial Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$603K Sell
4,324
-9
-0.2% -$1.26K 0.02% 368
2025
Q4 		$532K Buy
4,333
+123
+3% +$14.9K 0.02% 379
2025
Q3 		$467K Buy
4,210
+740
+21% +$84.1K 0.02% 385
2025
Q2 		$385K Buy
3,470
+390
+13% +$41.5K 0.01% 407
2025
Q1 		$345K Buy
3,080
+95
+3% +$9.8K 0.01% 410
2024
Q4 		$276K Sell
2,985
-58
-2% -$5.22K 0.01% 439
2024
Q3 		$255K Buy
+3,043
New +$232K 0.01% 451
2024
Q2 		– Sell
-3,026
Closed -$222K – 497
2024
Q1 		$222K Sell
3,026
-2,262
-43% -$174K 0.01% 477
2023
Q4 		$428K Buy
5,288
+2,446
+86% +$190K 0.02% 363
2023
Q3 		$213K Sell
2,842
-218
-7% -$16.8K 0.01% 406
2023
Q2 		$236K Buy
3,060
+91
+3% +$7.26K 0.01% 402
2023
Q1 		$246K Buy
2,969
+255
+9% +$21.1K 0.01% 380
2022
Q4 		$233K Buy
+2,714
New +$215K 0.01% 393

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Exencial Wealth Advisors's GILD Position: Q1 2026 in Review

Exencial Wealth Advisors reduced its Gilead Sciences (GILD) stake by 0.21% in Q1 2026, selling an estimated $1.26K and leaving 4,324 shares worth $603K. The position accounts for 0.02% of the portfolio, ranked #368.

Exencial Wealth Advisors first reported a position in GILD in Q4 2022 and has held it in 13 quarters since. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Exencial Wealth Advisors held 4,324 shares of Gilead Sciences worth $603K as of Q1 2026.
  • Exencial Wealth Advisors sold 9 Gilead Sciences shares in Q1 2026, an estimated $1.26K.
  • Gilead Sciences made up 0.02% of Exencial Wealth Advisors's portfolio in Q1 2026, its #368 holding.
  • Exencial Wealth Advisors first reported a position in Gilead Sciences in Q4 2022 and has held it in 13 quarters since.
  • 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.